Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-02-17

Clinical Trial Update: Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating treatment of asymptomatic fluid overload in peritoneal dialysis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Kidney Disease, Peritoneal Dialysis | Phase 4 | Status: WITHDRAWN